vancomycin has been researched along with Healthcare-Associated Pneumonia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; Tian, Z; Wang, M | 1 |
| Bruss, J; Dwyer, J; Jacobs, M; Lacy, MK; Nogid, B | 1 |
| Akizawa, K; Fukumoto, T; Kaku, N; Kimura, H; Konno, S; Morinaga, Y; Nagaoka, K; Suzuki, M; Yamashita, Y; Yanagihara, K | 1 |
1 review(s) available for vancomycin and Healthcare-Associated Pneumonia
| Article | Year |
|---|---|
A 600 mg of fixed-dose linezolid in renally impaired patients versus 15 mg/kg intermittent dose-optimized vancomycin in renally non-impaired patients: A single centre retrospective analysis for adult patients with hospital-acquired pneumonia due to methic
Topics: Adult; Anti-Bacterial Agents; Creatinine; Cross Infection; Healthcare-Associated Pneumonia; Hospitals; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Vancomycin | 2023 |
2 other study(ies) available for vancomycin and Healthcare-Associated Pneumonia
| Article | Year |
|---|---|
Time Course and Extent of Renal Function Changes in Patients Receiving Treatment for Staphylococcal Pneumonias: An Analysis Comparing Telavancin and Vancomycin from the ATTAIN Trials.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Creatinine; Female; Healthcare-Associated Pneumonia; Humans; Kidney Function Tests; Lipoglycopeptides; Male; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors; Vancomycin | 2018 |
Efficacy of Azithromycin in a Mouse Pneumonia Model against Hospital-Acquired Methicillin-Resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Antibiotic Prophylaxis; Azithromycin; Bacterial Toxins; Daptomycin; Disease Models, Animal; Drug Therapy, Combination; Healthcare-Associated Pneumonia; Hemolysin Proteins; Male; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Pneumonia, Staphylococcal; Vancomycin; Virulence Factors | 2019 |